Results
2303
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2303 companies
Regen BioPharma
Market Cap: US$1.1m
Focuses on the development of regenerative medical applications in the United States.
RGBP
US$0.042
7D
-31.5%
1Y
-91.7%
CYduct Diagnostics
Market Cap: US$1.1m
A healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions.
CYDX
US$0.20
7D
0%
1Y
-33.4%
Trevena
Market Cap: US$1.1m
A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.
TRVN
US$1.14
7D
4.6%
1Y
-88.4%
TransCanna Holdings
Market Cap: CA$1.4m
Through its subsidiaries, engages in the manufacturing, transportation, and distribution of cannabis related products in the United States.
TCAN
CA$0.01
7D
0%
1Y
-90.0%
Entheon Biomedical
Market Cap: CA$1.5m
Operates as a biotechnology research and development company.
ENBI
CA$0.11
7D
4.8%
1Y
-35.3%
TruSpine Technologies
Market Cap: UK£765.1k
A medical device company, engages in the development of spinal stabilization products in the United Kingdom and the United States.
TSP
UK£0.005
7D
0%
1Y
-81.8%
Braxia Scientific
Market Cap: CA$1.4m
Operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders.
BRAX
CA$0.005
7D
0%
1Y
-50.0%
Street Capital
Market Cap: CA$1.4m
Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.
STRC.X
CA$0.005
7D
0%
1Y
0%
Terranueva
Market Cap: CA$1.4m
Terranueva Corporation intends to produce cannabis for medical and recreational purposes.
TEQ
n/a
7D
n/a
1Y
n/a
Waverley Pharma
Market Cap: CA$1.4m
A biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom, European Union and North America.
WAVE
CA$0.015
7D
50.0%
1Y
-40.0%
Adastra Holdings
Market Cap: CA$1.3m
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada.
XTRX
CA$0.24
7D
-15.8%
1Y
-88.0%
Wellfully
Market Cap: AU$1.5m
Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies.
WFL
AU$0.003
7D
0%
1Y
-87.0%
Brain Scientific
Market Cap: US$932.0k
Brain Scientific Inc., a medtech company, provides neurology and motion products in the United States and internationally.
BRSF
US$0.75
7D
0%
1Y
-92.4%
PPJ Healthcare Enterprises
Market Cap: US$920.5k
Through its subsidiaries, provides automated healthcare reimbursement cycle, online health information digital-systems, and practice information management digital-system software to health care providers and general businesses worldwide.
PPJE
US$0.000001
7D
0%
1Y
-99.3%
CBD Life Sciences
Market Cap: US$918.7k
Engages in the development and marketing a line of cannabidiol based organic products.
CBDL
US$0.00025
7D
-16.7%
1Y
-96.4%
Iconic Labs
Market Cap: UK£669.7k
Does not have significant operations.
ICON
UK£0.06
7D
160.9%
1Y
n/a
WOWI
Market Cap: US$900.0k
An early-stage company, engages in the business of licensing technology and intellectual property to operators and businesses in the legal cannabis industry in the United States.
WOWU
US$0.027
7D
0%
1Y
n/a
NanoVibronix
Market Cap: US$896.0k
Through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing, and administration at home without the assistance of medical professionals.
NAOV
US$0.86
7D
-27.5%
1Y
-89.9%
Justera Health
Market Cap: CA$1.2m
Operates as a health and wellness management company in Canada.
VTAL
CA$0.005
7D
0%
1Y
-50.0%
Plandaí Biotechnology
Market Cap: US$888.9k
Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.
PLPL
US$0.0001
7D
9,900.0%
1Y
-75.0%
Psyence Group
Market Cap: CA$1.2m
A life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom.
PSYG
CA$0.13
7D
-13.3%
1Y
-65.3%
EV Biologics
Market Cap: US$880.4k
A biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics.
YECO
US$0.086
7D
0%
1Y
-84.5%
Lifeline Biotechnologies
Market Cap: US$869.8k
Operates as a medical technology company in the United States.
LLBO
US$0.0004
7D
33.3%
1Y
0%
ViaDerma
Market Cap: US$863.6k
Operates as a specialty pharmaceutical company in the United States.
VDRM
US$0.0007
7D
0%
1Y
-90.0%
RAMM Pharma
Market Cap: CA$1.2m
Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.
RAMM
CA$0.01
7D
0%
1Y
-60.0%
Dynatronics
Market Cap: US$861.2k
A medical device company, designs, develops, manufactures, markets, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States, Asia, Latin America, the Middle East, and internationally.
DYNT
US$0.081
7D
0%
1Y
-79.2%
Emmaus Life Sciences
Market Cap: US$849.4k
A commercial-stage biopharmaceutical company, discovers, develops, markets, and sells treatments and therapies primarily for rare and orphan diseases in the United States and internationally.
EMMA
US$0.013
7D
2.3%
1Y
-85.6%
AdAlta
Market Cap: AU$1.3m
A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.
1AD
AU$0.002
7D
-33.3%
1Y
-92.0%
SQZ Biotechnologies
Market Cap: US$825.8k
A clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions.
SQZB
US$0.028
7D
0%
1Y
-43.7%
MediXall Group
Market Cap: US$800.9k
Provides health solutions in the United States.
MDXL
US$0.0039
7D
0%
1Y
n/a
Panacea Life Sciences Holdings
Market Cap: US$792.7k
Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.
PLSH
US$0.037
7D
2.0%
1Y
-74.8%
LadRx
Market Cap: US$787.2k
A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.
LADX
US$1.59
7D
0%
1Y
-45.2%
Avenue Therapeutics
Market Cap: US$786.8k
A specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.
ATXI
US$0.26
7D
18.1%
1Y
-93.0%
UA Multimedia
Market Cap: US$781.6k
A media company, engages in Web, mobile applications, and film production and distribution activities.
UAMM
US$0.0024
7D
-4.0%
1Y
-0.2%
Hepion Pharmaceuticals
Market Cap: US$779.3k
A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC) and other chronic liver diseases in the United States.
HEPA
US$0.065
7D
-15.8%
1Y
-99.9%
Pharmadrug
Market Cap: CA$1.1m
Operates as a specialty pharmaceutical company.
PHRX
CA$0.01
7D
0%
1Y
-66.7%